NICE u-turn backs Sanofi’s Gaucher disease drug

1st June 2017 Uncategorised 0

It is now looking likely that Sanofi’s Cerdelga will be funded on the NHS in England and Wales to treat type 1 Gaucher disease, after a u-turn by cost regulators.

More: NICE u-turn backs Sanofi’s Gaucher disease drug
Source: News